Oura–Ultrahuman Lawsuit: What Ring Pro Buyers Need to Know
Oura says Ultrahuman’s Ring Pro infringes two patents and seeks to block U.S. sales. See what the lawsuit means for buyers, rivals and the smart ring market.
Oura's New Ultrahuman Lawsuit Puts Ring Pro's U.S. Future in Focus
Ultrahuman's Ring Pro is back in the U.S. after a redesign cleared a Customs review. Now, Oura is challenging that comeback with a fresh patent lawsuit, alleging the Ring Pro infringes two Oura patents and asking a federal court to award damages and block U.S. sales.
This doesn't mean the Ring Pro is automatically banned. Ultrahuman's co-founder and CEO says the company will fight the claims, and there's no court order affecting the product's availability. Still, the dispute is bigger than one ring: it's another move in Oura's push to enforce its smart-ring patents against competitors, and it puts Ultrahuman's legal path in the U.S. under closer scrutiny.
For buyers, the immediate question is simple: can you still purchase the Ring Pro? For both companies, the bigger questions are what the patents cover, whether the redesign avoids them, and how much influence intellectual-property fights will have as smart rings keep gaining traction. Here's what's known, what's unclear, and what to watch next.
What Oura is alleging
Oura's complaint targets Ultrahuman's Ring Pro, a redesigned smart ring launched in February. Filed in federal court in Texas on October 22, 2026, the lawsuit alleges infringement of two Oura patents: D804,471 and 12,769,363. Oura is seeking monetary damages and a permanent injunction that would stop the ring's sale in the United States.
These are allegations, not a ruling. The case is just starting the process where each side can contest the claims, the patent scope, and the evidence. Ultrahuman says it's confident in the Ring Pro and will defend its position. In its response, the company said no court order affects the product and that it remains available to U.S. customers.
The patents at the centre of the case
Oura says its patents cover design aspects and internal components of the ring. Its complaint describes patent 12,769,363 as covering a smart-ring design that includes components such as a curved battery, circuit board, magnets, and sensors. Oura says the patent was issued on October 20 - two days before the lawsuit was filed.
The timing may look meaningful, but it doesn't settle the dispute by itself. A newly issued patent doesn't automatically mean another product infringes it. The court will have to review the patent's claims, compare them to the Ring Pro, and decide how the evidence and arguments apply. Ultrahuman says it plans to address the claims through the legal process.
Oura also argues that the earlier Customs decision that cleared the Ring Pro back into the U.S. was about a different patent. In Oura's view, that review covered the patent at issue in the prior dispute - not the two patents named in this new case. In other words, Oura says a redesign may have fixed one import-related problem, but it doesn't automatically resolve separate allegations tied to different patents.
Why SVTronics is also named
Oura lists SVTronics, a Texas-based electronics manufacturer, as a defendant along with Ultrahuman. Oura alleges SVTronics manufactures the Ring Pro at a Plano, Texas facility under Ultrahuman's direction and control. Oura further alleges both companies infringe the patents through manufacturing, importing, and selling the device in the U.S.
Including a manufacturer brings the supply chain into the case, not just the question of whether two consumer brands are in conflict. It can also matter if a requested remedy involves how products are made as well as sold. But naming SVTronics doesn't, by itself, prove infringement by either company - those issues still need to be litigated.
This case also highlights how product design and production decisions can become legal issues, not only engineering ones. A small device can combine a distinctive external form with tightly packed electronics. If a patent claim covers the components or how they're arranged, changing the look alone may not address everything a competitor alleges. Whether that's true here is something the court will decide.
Why Ultrahuman's U.S. comeback is at stake
This isn't the first Oura-Ultrahuman patent dispute. Oura sued over Ultrahuman's earlier Ring Air in 2023, then brought a separate case before the U.S. International Trade Commission in 2024. Oura won an ITC ruling in August 2025, and an import ban on the Ring Air followed.
Ultrahuman responded with the Ring Pro. In March 2026, U.S. Customs and Border Protection issued a favorable ruling that cleared the startup's return to the U.S. market. Oura's latest lawsuit tests how far that clearance goes. Oura's position is that the Customs ruling addressed only the patent tied to the earlier dispute, while the new complaint involves two different patents.
A regulatory clearance is not a blanket guarantee
It's tempting to treat a product clearance as a full "you're good to go" verdict. But in practice, a decision from one proceeding can be limited to a narrow question - whether a particular product, design, or patent issue falls within that specific review. It doesn't necessarily prevent a competitor from bringing a separate claim based on different intellectual property.
That's the gap between what happened with the Ring Pro at Customs and what Oura is now alleging in court. Ultrahuman points to the Customs decision as part of why it returned to the U.S. Oura argues that the decision didn't resolve the patents now at issue. The two positions can coexist until a court - or another relevant authority - addresses the new claims.
For companies building hardware, this is a reminder that "cleared" doesn't always mean "freedom to operate across the board." A redesign can fix one specific objection while leaving other questions open. Figuring those questions out early can be expensive and time-consuming, but discovering them after launch can be even harder - especially if the U.S. is a key market.
The market consequences of another legal fight
Oura is asking for a permanent injunction. The court hasn't granted anything yet. If the case advances, the outcome could affect whether Ring Pro sales continue in the U.S., or whether changes, licensing talks, or other remedies become part of any resolution. The complaint itself doesn't set the timing or the outcome.
Still, uncertainty can show up before a final decision. Retailers, distributors, and customers might factor in the risk of interruptions when planning purchases and inventory. A hardware company may also have to pull leadership, engineering, and legal resources into the dispute while it's trying to improve the product and expand distribution. Those can be real business impacts - without proving in advance that sales will stop.
For Ultrahuman, the practical message is that the product is still available and that no court order currently affects it. Buyers should use current availability and official updates rather than assuming that the suit has already removed the ring from sale or that its long-term U.S. status is locked in.
What the dispute means for buyers and competitors
For consumers, this is primarily a legal and market-development story, not a new head-to-head comparison of health-tracking performance. The complaint is about patents, and it doesn't establish that one ring measures health metrics more accurately than another, or that the lawsuit changes the Ring Pro's features on its own. If you're considering a Ring Pro, the useful questions are practical: can you buy it now, what are the support and return terms, and what happens if availability changes later?
Those questions matter for any connected device - especially in a relatively young category where vendors and product lines are still shifting. This doesn't mean people need to avoid the Ring Pro. It does mean buyers should separate "available today" from what a court might decide later.
Oura's litigation reaches beyond Ultrahuman
Oura has pursued patent infringement claims against multiple smart ring makers, including Samsung, RingConn, Circular, and Zepp Health. Some disputes have reportedly ended with licensing agreements. According to the source report, RingConn and Circular agreed to pay royalties to Oura to continue selling their products.
That pattern suggests there's no single "one way this goes" outcome. A case can be contested, settled, licensed, or resolved through other legal paths. One company's result doesn't automatically predict another's, since the patents, product designs, and facts can differ. Still, licensing deals show how patent enforcement can shape commercial terms even when a competitor's product stays on the market.
For a smaller company, it's not only a "win or lose" question. The real trade-offs can be different: litigation costs versus the cost of a license, a design change, or a restricted launch. A license might protect market access but add ongoing expenses. A redesign might require engineering work and delay. Litigation might defend a position, but it can also consume time and money with no guaranteed outcome.
Growth raises the stakes
This dispute lands as the category expands. IDC expects global smart ring shipments to rise 12.8% in 2026 to 4.9 million units, then reach about 6.3 million by 2030. Oura remains a leading player, while Ultrahuman is among the competitors trying to gain share.
As the market grows, intellectual property can become strategic - helping companies protect product development, support licensing revenue, or define where competitors can operate. At the same time, enforcement adds uncertainty for the category overall. If multiple manufacturers face overlapping claims, new entrants may need to budget for legal review and potential licensing alongside product development and customer acquisition.
There's also the companies' forward-looking bets. Oura has kept adding features, including new fitness metrics meant to help users understand how workouts affect cardiovascular health. Ultrahuman raised $70 million in September from investors including Qualcomm Ventures and Labcorp, at a reported valuation of about $365 million. Ultrahuman is also working with Qualcomm on a ring designed to run more software directly on the device, with plans that go beyond health and fitness tracking into areas like AI interactions and gaming.
Those plans make this dispute relevant beyond the Ring Pro. Next-gen smart rings may pack more sensors, more software, and more on-device processing into the same small form factor. Patent questions about design and components could stay part of the competition as products evolve. That's something to watch, not a conclusion about the merits of this specific lawsuit.
What to watch next
The next updates will come from what happens in the case and from what the companies announce along the way. A complaint lays out one side's claims, but it isn't the final word. Watch for Ultrahuman's formal response, any court rulings tied to requests for relief, and any settlement or licensing announcement. Also keep an eye on product availability updates from the companies and retailers.
A practical checklist for Ring Pro buyers
If you're shopping for a smart ring, keep the decision tied to what you need - not just lawsuit headlines:
- Check availability at the time you buy. Ultrahuman says the lawsuit has not resulted in an order stopping U.S. sales.
- Review the seller's return and warranty terms. These matter regardless of the legal dispute and can be especially important if your plans change.
- Separate product capability from legal risk. The lawsuit doesn't resolve questions about comfort, battery life, health features, or compatibility.
- Follow updates from both companies. A new court order or business agreement could change the situation; the filing alone doesn't.
For competitors and product teams, the takeaway is broader. Patent review should be part of product planning, not treated as a final paperwork step after hardware is already locked in. That doesn't mean every company should avoid contested markets or stop building whenever a rival asserts a patent. It does mean teams should identify the relevant claims, understand the uncertainty, and make a deliberate choice about the costs of redesign, licensing, or litigation.
Oura's $2.2 billion IPO has also been shelved, according to the source report, with the company pointing to market "uncertainty." That provides useful business context, but it doesn't prove this lawsuit caused the IPO decision. The legal case, product expansion, and financing environment are separate developments that could all shape how investors and customers see the smart ring space.
For a detailed account of the filing and company statements, see TechCrunch's report on Oura's lawsuit.
Conclusion
Oura's lawsuit adds a new legal risk for Ultrahuman's U.S. smart ring business, but it hasn't stopped Ring Pro sales yet. The key distinction is between an allegation and a court decision: Oura says two patents are infringed and is seeking damages and an injunction, while Ultrahuman says it will contest the claims and that no court order currently affects the product.
If you're a buyer, start by checking current availability and purchase terms, then judge the ring based on the features you actually want. For the companies, the case is another test of how patent rights, product redesign, and competition will coexist as the category grows. For more detail, rely on formal court updates rather than treating either side's position as the final outcome. For additional context, read the original report.